Sohaib Mir
Directeur/Membre du Conseil chez Montis Biosciences BV
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| John McCafferty | M | 66 |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | 4 ans |
| Aneesh Karatt-Vellatt | M | 37 |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | 4 ans |
| Siddharthan Chandran | M | 58 |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | 6 ans |
| Robert Sprawson | M | 53 |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | 5 ans |
| Fraser Murray | M | 53 |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | 2 ans |
| Rana Al-Hallaq | M | - |
Montis Biosciences BV
 Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
| Jane Rhodes | M | 56 |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | - |
| Sylwia Szulc | F | - |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | 5 ans |
| Victoria Woodward | F | - |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | 5 ans |
| Imran Hamid | M | - |
Lifearc Ventures
 Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | 3 ans |
| Katie Sunnucks | F | - |
Alsa Management Services Ltd
 Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | 5 ans |
| Lucy Edwardes Jones | F | - |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | 1 ans |
| Ellie McGuire | F | - |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
| Raj Bhikhu Parekh | M | 63 |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | - |
| Chris Baker | M | - |
Lifearc Ventures
Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | 3 ans |
| Jonathan Nash | M | - |
Lifearc Ventures
Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | - |
| Tim Funnell | M | - |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | 2 ans |
| Lorna Yvonne Collings | F | 49 |
Alsa Management Services Ltd
Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | 5 ans |
| Griet Vanpoucke | M | - |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
| David A. Holbrook | M | - |
Lifearc Ventures
Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | - |
| Luc Dochez | M | 49 |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
| Michael Anstey | M | 43 |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | 7 ans |
| Eva-Lotta Allan | F | 65 |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | 1 ans |
| Timothy Harris | M | 74 |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | - |
| Thomas Weaver | M | - |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | - |
| Andrew Williamson | M | 53 |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | 8 ans |
| Clare Elizabeth Terlouw | F | 51 |
Lifearc Ventures
Lifearc Ventures Investment ManagersFinance Lifearc Ventures (Lifearc Ventures) is a venture capital firm, a subsidiary of Lifearc. The firm is headquartered in London, United Kingdom. | 4 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Ciarán Coyle | M | - |
University of Cambridge
| 12 ans |
| Laura Morrill | F | - |
University of Cambridge
| 4 ans |
| Alexander Katsis | M | - |
University of Cambridge
| 4 ans |
| Rosemary Bradley | F | - |
University of Cambridge
| 4 ans |
| Wu Lin | M | - |
University of Cambridge
| 4 ans |
| Harry Simpson | M | - |
University of Cambridge
| 4 ans |
| Jack Weller | M | - |
University of Cambridge
| 3 ans |
| Avinash Sukhwani | M | - |
University of Cambridge
| 3 ans |
| He Nan Song | M | 32 |
University of Cambridge
| 4 ans |
| Stephanie Lipman | F | - |
University of Cambridge
| 4 ans |
| Yin On Choi | M | 40 |
University of Cambridge
| 2 ans |
| Timothy Khoury | M | - |
University of Cambridge
| 5 ans |
| Adam Knight | M | - |
University of Cambridge
| 4 ans |
| nick Davies | M | - |
University of Cambridge
| 4 ans |
| Joe Bond | M | - |
University of Cambridge
| 3 ans |
| Christopher Tapper | M | - |
University of Cambridge
| 3 ans |
| Maria Sidoli | F | - |
University of Cambridge
| 3 ans |
| Alexander Fridman | M | - |
University of Cambridge
| 2 ans |
| Matt Cohen | M | - |
University of Cambridge
| 1 ans |
| Donauly Elena Situmorang | F | 41 |
University of Cambridge
| 2 ans |
| Macadam James | M | - |
University of Cambridge
| 1 ans |
| Philipp Leitner | M | - |
University of Cambridge
| 1 ans |
| Alexander Cakir | M | - |
University of Cambridge
| 3 ans |
| Kan Ye | M | - |
University of Cambridge
| 1 ans |
| Jamie Gilbert | M | - |
University of Cambridge
| 4 ans |
| justin woolf | M | - |
University of Cambridge
| 3 ans |
| Jasmin Hu | F | - |
University of Cambridge
| 3 ans |
| Zheng Chang Zhu | M | 64 |
University of Cambridge
| 2 ans |
| Stefan Zlatev | M | - |
University of Cambridge
| 1 ans |
| Allison Hinckley | M | - |
University of Cambridge
| 1 ans |
| Andrew Stone | M | - |
University of Cambridge
| 4 ans |
| Ravi Shah | M | - |
University of Cambridge
| 3 ans |
| Chris Wallace | M | - |
University of Cambridge
| 4 ans |
| Sophie Bell | F | - |
University of Cambridge
| 4 ans |
| Meg Uthayophas | F | - |
University of Cambridge
| 3 ans |
| Thayne Forbes | M | - |
University of Cambridge
| 4 ans |
| Zoe Lai | F | - |
University of Cambridge
| 3 ans |
| Alex Hamilton | M | - |
University of Cambridge
| 3 ans |
| Olivia Nicoletti | F | - |
University of Cambridge
| 4 ans |
| Carlos Morales | M | - |
University of Cambridge
| 1 ans |
| Baljeet Grewal | F | 48 |
University of Cambridge
| 2 ans |
| Gareth Jefferies | M | - |
University of Cambridge
| 3 ans |
| Pawel Wieprzowski | M | - |
University of Cambridge
| 1 ans |
| Livia Chan | F | - |
University of Cambridge
| 3 ans |
| Charles Street | M | 34 |
University of Cambridge
| 3 ans |
| Fan Yang | M | 37 |
University of Cambridge
| 4 ans |
| Vanina El-Khoury | F | - |
University of Cambridge
| 1 ans |
| Cheuk Man Hung | F | 33 |
University of Cambridge
| 4 ans |
| Thomas Sawyer | M | 54 |
University of Cambridge
| 2 ans |
| Francis Chiu | M | 61 |
University of Cambridge
| 2 ans |
| Andrew Gillin | M | - |
University of Cambridge
| 2 ans |
| Himanshu Bindal | M | - |
University of Cambridge
| 1 ans |
| Benjamin Fried | M | - |
University of Cambridge
| 3 ans |
| Jack Davies | M | - |
University of Cambridge
| 3 ans |
| Edward Inns | M | - |
University of Cambridge
| 4 ans |
| Rory Nath | M | - |
University of Cambridge
| 4 ans |
| Juan Carlos Sanchez | M | - |
University of Cambridge
| 1 ans |
| Irina Shaorshadze | M | - |
University of Cambridge
| 3 ans |
| Ryan Harrison | M | - |
University of Cambridge
| 1 ans |
| Sharukh Malik | M | - |
University of Cambridge
| 3 ans |
| David Goldberg | M | - |
University of Cambridge
| 1 ans |
| Matt Bennison | M | - |
University of Cambridge
| 4 ans |
| Christos Lavidas | M | - |
University of Cambridge
| 3 ans |
| Catherine Pelton Pelton | F | - |
University of Cambridge
| 4 ans |
| Damien Beslee | M | - |
University of Cambridge
| 3 ans |
| Julia Guimaraes | F | - |
University of Cambridge
| 3 ans |
| Daniel Rix Standing | M | - |
University of Cambridge
| 3 ans |
| Michael Zhang | M | - |
University of Cambridge
| 4 ans |
| Emil Hewage | M | - |
University of Cambridge
| 4 ans |
| Seyed-Mahdi Khaligh-Razavi | M | 35 |
University of Cambridge
| 3 ans |
| Martin Ericsson | M | - |
University of Cambridge
| 1 ans |
| Matthias Fink | M | 38 |
University of Cambridge
| 1 ans |
| Katie Lockwood | F | - |
University of Cambridge
| 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Royaume-Uni | 96 | 96,00% |
| Belgique | 4 | 4,00% |
| Etats-Unis | 0 | -.--% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Sohaib Mir
- Réseau Personnel
